Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer

PURPOSE: Small-cell neuroendocrine prostate cancer (SCNPC) exhibits an aggressive clinical course and incidence rates appear to be increasing following resistance to potent androgen receptor (AR) antagonists. Currently, treatment options are limited and few model systems are available to identify ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Corella, Alexandra N., Ordonio, Ma Victoria Andrea Cabiliza, Coleman, Ilsa, Lucas, Jared M., Kaipainen, Arja, Nguyen, Holly M., Sondheim, Daniel, Brown, Lisha G., True, Lawrence, Lee, John, MacPherson, David, Nghiem, Paul, Gulati, Roman, Morrissey, Colm, Corey, Eva, Nelson, Peter S.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7124974/
https://ncbi.nlm.nih.gov/pubmed/31806643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-0775
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars